News

U.S.

U.S. Reaches Deal to Pay Pfizer and BioNTech $2 Billion for 100 Million Coronavirus Vaccine Doses

Lab equipment is seen at Cobra Biologics, scientists are working on a potential vaccine for COVID-19, following the outbreak of the coronavirus disease (COVID-19), in Keele, Britain, April 30, 2020. (REUTERS/Carl Recine)

The U.S. on Wednesday announced an agreement to pay pharmaceutical giant Pfizer and biotech firm BioNTech nearly $2 billion for 100 million doses of their coronavirus vaccine.

The Department of Health and Human Services and the Defense Department will acquire 100 million doses of the experimental vaccine under the $1.95 billion deal with Germany-based BioNTech and New York City-based Pfizer. The U.S. can also obtain an additional 500 million doses of the vaccine, developed jointly by the companies.

The doses are expected to be made available to Americans “at no cost,” provided the vaccine passes a large phase-three clinical trial and is approved by the Food and Drug Administration, HHS said. A large trial with up to 30,000 participants is slated to begin later this month, the companies said.

The agreement is the largest of several recent deals the Trump administration has made to acquire experimental coronavirus vaccines as part of its “Operation Warp Speed.”

“Through Operation Warp Speed, we are assembling a portfolio of vaccines to increase the odds that the American people will have at least one safe, effective vaccine as soon as the end of this year,” HHS Secretary Alex Azar said in a statement Wednesday. “Depending on success in clinical trials, today’s agreement will enable the delivery of approximately 100 million doses of vaccine being developed by Pfizer and BioNTech.”

The U.S. also struck a $1.2 billion deal with AstraZeneca for at least 300 million doses of a vaccine developed by scientists at the University of Oxford, an early human trial of which yielded a strong immune response in hundreds of people. Another $1.6 billion agreement with Novavax will fund testing and manufacturing of a vaccine with a goal of acquiring 100 million doses by January. The government has reached agreements to invest millions of dollars in vaccines developed by Johnson & Johnson, Moderna, and Emergent Biosolutions as well.

At least 23 of about 100 experimental coronavirus vaccines have reached the human trial stage. Widespread availability of a vaccine for the coronavirus, which has infected more than 14 million people globally and killed more than 606,200, is expected next year if trials are successful.

Send a tip to the news team at NR.

Most Popular

Immigration

What Now for Trump’s Border Wall?

The verdict on the U.S.–Mexico border wall President Trump promised to construct is decidedly mixed as the year comes to a close. The “big, beautiful wall,” as Trump referred to it, reached 400 miles in length by the end of October, when the Department of Homeland Security held a ceremony hailing the ... Read More
Immigration

What Now for Trump’s Border Wall?

The verdict on the U.S.–Mexico border wall President Trump promised to construct is decidedly mixed as the year comes to a close. The “big, beautiful wall,” as Trump referred to it, reached 400 miles in length by the end of October, when the Department of Homeland Security held a ceremony hailing the ... Read More

The Imaginary Trump

Like Andrew Jackson, Donald Trump is man who represents the age in which he lived. Whatever you may think of the age. Jackson embodied a generation of men who had risen and made their mark in a young country. He represented their desire for greater representation, even if it had costs for slaves and Indians. He ... Read More

The Imaginary Trump

Like Andrew Jackson, Donald Trump is man who represents the age in which he lived. Whatever you may think of the age. Jackson embodied a generation of men who had risen and made their mark in a young country. He represented their desire for greater representation, even if it had costs for slaves and Indians. He ... Read More
Film & TV

Bowing Down to Obama

‘How can we miss you when you won’t go away?” political podcaster Yvette Carnell joked two years ago when Barack Obama began his comeback tour by making sideline pronouncements about the state of the nation after his brief retirement. Now the comeback is official, with two new Kool-Aid-drinker Obama ... Read More
Film & TV

Bowing Down to Obama

‘How can we miss you when you won’t go away?” political podcaster Yvette Carnell joked two years ago when Barack Obama began his comeback tour by making sideline pronouncements about the state of the nation after his brief retirement. Now the comeback is official, with two new Kool-Aid-drinker Obama ... Read More
Economy & Business

Shopping Superstitions

It’s the boss-bossiest time of the year, when Americans getting ready to open up their wallets to buy Christmas presents are lectured by illiterate halfwits about where and how to spend their money. The usual demands: Buy local, or buy from small businesses. This is pure nonsense, and you should feel free to ... Read More
Economy & Business

Shopping Superstitions

It’s the boss-bossiest time of the year, when Americans getting ready to open up their wallets to buy Christmas presents are lectured by illiterate halfwits about where and how to spend their money. The usual demands: Buy local, or buy from small businesses. This is pure nonsense, and you should feel free to ... Read More
Media

Wajahat Ali, Ctd.

I gather he didn’t like my comment on his New York Times op-ed on the folly of reaching out to Trump supporters. He snipes, “I await The National Review’s piece on reaching out to Biden voters and reading about their ‘elegy’ and understanding their ‘economic anxiety.’” After the 2016 election, ... Read More
Media

Wajahat Ali, Ctd.

I gather he didn’t like my comment on his New York Times op-ed on the folly of reaching out to Trump supporters. He snipes, “I await The National Review’s piece on reaching out to Biden voters and reading about their ‘elegy’ and understanding their ‘economic anxiety.’” After the 2016 election, ... Read More
World

A Moveable Feast?

Last week a unique but apposite tribute was paid in Budapest to the late Sir Roger Scruton, the distinguished Tory philosopher who died earlier this year: A café was opened in his name. It goes under the designer label “Scruton—The Place to be” and is situated three blocks from the Hungarian Parliament at ... Read More
World

A Moveable Feast?

Last week a unique but apposite tribute was paid in Budapest to the late Sir Roger Scruton, the distinguished Tory philosopher who died earlier this year: A café was opened in his name. It goes under the designer label “Scruton—The Place to be” and is situated three blocks from the Hungarian Parliament at ... Read More